SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001558370-22-016533
Filing Date
2022-11-07
Accepted
2022-11-07 09:34:27
Documents
4
Period of Report
2022-11-07

Document Format Files

Seq Description Document Type Size
1 6-K/A tmb-20221107x6ka.htm 6-K/A 27131
2 EX-99.1 tmb-20221107xex99d1.htm EX-99.1 428687
3 EX-99.2 tmb-20221107xex99d2.htm EX-99.2 389178
4 GRAPHIC tmb-20221107xex99d1001.jpg GRAPHIC 4330
  Complete submission text file 0001558370-22-016533.txt   852076
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 6-K/A | Act: 34 | File No.: 001-35773 | Film No.: 221364056
SIC: 2834 Pharmaceutical Preparations